Estée Lauder lifts outlook as its earnings rally fades

A stronger quarter, a fading share-price rally

Estée Lauder raised its annual forecast on Monday, November 2, after a stronger first quarter ended September 30, 2026. Net sales rose 7% to US$3.715 billion from US$3.481 billion. Reported diluted earnings per share reached US$0.64 versus US$0.13; adjusted EPS, a non-GAAP measure, rose to US$0.72 from US$0.32. That adjusted increase is 125%. [1]

The stock did not simply follow the better results higher. Yahoo Finance’s November 2 snapshot, timestamped 11:23:49 EST, showed US$108.895, down US$0.335, or 0.31%, from Friday’s US$109.23 close. Earlier, it had reached US$113.50, roughly 3.91% above that close. Volume was 2,883,678 shares at the snapshot: an incomplete session, not a closing total or evidence of sustained buying. [6]

Why fragrance is doing the heavy lifting

Fragrance organic sales jumped 20%, led by luxury brands including Le Labo, TOM FORD, Jo Malone London and KILIAN PARIS. Skin care grew 4% organically and makeup 1%; hair care was flat. Organic growth excludes currency translation and certain other non-comparable items, so it should not be confused with reported sales growth. [1]

• China and travel retail contributed: mainland China organic sales grew 9%, while the Asia/Pacific region grew 10%. Management cited replenishment orders at Beijing and Shanghai airports and improved online Hainan retail sales. [1]
• Procurement savings, manufacturing efficiencies and pricing helped adjusted gross margin reach 75.7%, from 73.3%. Adjusted operating margin rose 4.8 percentage points to 12.1%. [1]
• This was not only a spending retreat: consumer-facing investment increased 8%. The test is whether that support produces durable demand rather than a one-quarter shipment rebound. [1]

The new organic-growth midpoint is 4.75%, versus 4% previously. The adjusted-EPS range rose by US$0.10 at both ends; its midpoint increased about 3.10%. That is a meaningful upgrade, but smaller than the quarterly EPS jump. Adjusted figures remove specified items and are not substitutes for the reported accounts. [1]

Beauty is resilient, but not immune

There is supporting sector evidence, not a blank cheque. L’Oréal reported third-quarter sales of €11.5614 billion, up 7.2% like-for-like, in its October 22 release; it also identified fragrances as a growth driver. Its business mix and growth definitions differ from Estée Lauder’s, so this is context, not a direct scorecard or proof that every beauty company benefits equally. [2]

Household budgets still matter. The latest U.S. CPI release, covering September and published October 14, showed prices up 3.7% over twelve months, before seasonal adjustment, and 0.6% month-on-month seasonally adjusted. That is a consumer-spending headwind to monitor, not an established explanation for EL’s intraday reversal. Price data alone cannot identify the sellers’ motives. [3]

What it means for option sellers

Cboe’s delayed research snapshot, retrieved November 2 at 11:23 EST, showed indicative 30-day implied volatility of 43.872%, down 10.386 percentage points in the feed’s change field. IV rank was not independently verified. The observation is consistent with post-results volatility compression, but does not establish that any particular option is attractive. These are timestamped research figures, not live premiums; check live prices before trading. [5]

The wheel means potentially buying shares through put assignment, then selling covered calls against shares. A cash-secured put retains substantial stock downside; a covered call limits upside without eliminating downside. Today’s earnings release is already out, but that does not make November expiries event-free. [1,8,9]

• Calendar check: the November 4 presentation and November 6 U.S. jobs release fall before the illustrative November 20 expiry. [4,10]
• Risk check: an educational review considers bid/ask spreads, open interest, assignment exposure and whether owning the shares would be tolerable; no executable setup is rated here. [8,9]
• Management check: a lower IV reading can reduce an option’s value, all else equal, but an adverse share-price move can outweigh that effect. A premium is not a downside shield. [8,9]

What to watch next

• November 4: Capital Markets Experience presentations from Shanghai, focused on the China growth strategy. [4]
• November 6, 8:30 a.m. ET: October U.S. employment report. November 10, 8:30 a.m. ET: October CPI. Both are scheduled releases, not known outcomes. [10]
• November 30: dividend record date; December 15: US$0.35-per-share payment. The record date is not asserted here to be an ex-dividend date. [1]
• February 3, 2027, 8:30 a.m. ET: next scheduled earnings webcast. Watch cash conversion as well as fragrance growth and margins. [4]

Hero: archival 2015 retail photograph by bargainmoose / bargainmoose.ca via Flickr and Wikimedia Commons, cropped and resized under CC BY 2.0. It does not show today’s earnings event. Source and license: [11,12].